1. 1044Efficacy of Ceftolozane/Tazobactam vs Levofloxacin in the Treatment of Complicated Urinary Tract Infections (cUTI) caused by Levofloxacin-resistant Pathogens: Results from the ASPECT-cUTI Trial. (December 2014) Authors: Sakoulas, George; Umeh, Obiamiwe; Huntington, Jennifer; Cloutier, Daniel; Steenbergen, Judith; Yuan, Guojun; Yoon, Minjung; Goldstein, Ellie Journal: Open forum infectious diseases Issue: Volume 1(2014)Supplement 1 Page Start: S306 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 251Characteristics and Outcomes of Complicated Intra-abdominal Infections Involving Pseudomonas aeruginosa from a Phase 3 Ceftolozane/Tazobactam Study. (December 2014) Authors: Miller, Benjamin; Wooley, Myra; Hershberger, Ellie; Steenbergen, Judith; Busa, Bhavin; Yuan, Guojun; Mensah, Robert; Friedland, Ian; Alverdy, John Journal: Open forum infectious diseases Issue: Volume 1(2014)Supplement 1 Page Start: S108 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 260Ceftolozane/Tazobactam for the Treatment of cUTI and cIAI Caused by ESBL-producing Enterobacteriaceae. (December 2014) Authors: Popejoy, Myra; Cloutier, Daniel; Huntington, Jennifer; Steenbergen, Judith; Hershberger, Ellie; Umeh, Obiamiwe; Miller, Benjamin; Kaye, Keith Journal: Open forum infectious diseases Issue: Volume 1(2014)Supplement 1 Page Start: S111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Ceftolozane-tazobactam compared with levofloxacin in the treatment of complicated urinary-tract infections, including pyelonephritis: a randomised, double-blind, phase 3 trial (ASPECT-cUTI). Issue 9981 (16th May 2015) Authors: Wagenlehner, Florian M; Umeh, Obiamiwe; Steenbergen, Judith; Yuan, Guojun; Darouiche, Rabih O Journal: Lancet Issue: Volume 385:Issue 9981(2015) Page Start: 1949 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Discovery, pharmacology, and clinical profile of omadacycline, a novel aminomethylcycline antibiotic. Issue 24 (15th December 2016) Authors: Tanaka, S. Ken; Steenbergen, Judith; Villano, Stephen Journal: Bioorganic & medicinal chemistry Issue: Volume 24:Issue 24(2016) Page Start: 6409 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Omadacycline: development of a novel aminomethylcycline antibiotic for treating drug-resistant bacterial infections. (November 2016) Authors: Villano, Stephen; Steenbergen, Judith; Loh, Evan Journal: Future microbiology Issue: Volume 11:Number 11(2016:Nov.) Page Start: 1421 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Outcomes of high-dose levofloxacin therapy remain bound to the levofloxacin minimum inhibitory concentration in complicated urinary tract infections. Issue 1 (December 2016) Authors: Armstrong, Eliana; Mikulca, Janelle; Cloutier, Daniel; Bliss, Caleb; Steenbergen, Judith Journal: BMC infectious diseases Issue: Volume 16:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗